Welcome to LookChem.com Sign In|Join Free
  • or
1-Propanol, 3-(phenylmethoxy)-2,2-bis[(phenylmethoxy)methyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

433686-87-4

Post Buying Request

433686-87-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

433686-87-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 433686-87-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,6,8 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 433686-87:
(8*4)+(7*3)+(6*3)+(5*6)+(4*8)+(3*6)+(2*8)+(1*7)=174
174 % 10 = 4
So 433686-87-4 is a valid CAS Registry Number.

433686-87-4Relevant academic research and scientific papers

Olefin self-metathesis as a new entry into xenotransplantation antagonists bearing the Galili antigen

Liu, Bingcan,Roy, Rene

, p. 594 - 595 (2002)

A hexameric disaccharide cluster bearing the terminal Galα related xenotransplantation antigen was constructed using a sequence of ruthenium carbenoid catalyzed olefin self-metathesis of monoallylated tribenzyl pentaerythritol followed, after interconvers

Syntheses of monohydroxy benzyl ethers of polyols: Tri-O- benzylpentaerythritol and other highly benzylated derivatives of symmetrical polyols

Al-Mughaid, Hussein,Grindley, T. Bruce

, p. 2607 - 2610 (2004)

Symmetrical polyols can be converted into benzyl ethers with one free hydroxyl group in good yield by reaction of the monodibutylstannylene acetal with excess benzyl bromide in the presence of tetrabutylammonium bromide and diisopropylethylamine in xylene. The reaction pathway involves initial benzylation of the dibutylstannylene acetal to give benzyl and bromodibutylstannyl ethers; if a hydroxyl group remains unsubstituted, the latter ether ring closes and reacts further.

Efficient synthesis and properties of soluble aliphatic oligo(spiroorthocarbonate)s from pentaerythritol derivatives

Mori, Yasuyuki,Sudo, Atsushi,Endo, Takeshi

, p. 792 - 798 (2019)

A series of soluble oligo(spiroorthocarbonate)s (OSOCs) were synthesized by polycondensation of tetraethylorthocarbonate with pentaerythritol derivatives. The pentaerythritol derivatives used herein were synthesized from pentaerythritol by attaching subst

Synthesis of new cores and their use in the preparation of polyester dendrimers

Twibanire, Jean-D'Amour K.,Al-Mughaid, Hussein,Grindley, T. Bruce

experimental part, p. 9602 - 9609 (2011/01/03)

Six dendrimer and dendron cores terminated by hydroxyl groups that are neither phenolic nor cleavable by hydrogenolysis have been prepared in a consistent one-pot manner from terminal allyl groups by reduction of the product of reductive ozonolysis. Some of the terminal allyl derivatives are new and others have been prepared by new methods. The well-known O-benzylidene derivative of 2,2′-bis(hydroxymethyl)propanoic acid was shown to be the cis-stereoisomer. A new AB3-type anhydride, tris(benzyloxymethyl) acetic anhydride has been prepared. It was demonstrated that these cores and dendrons could be assembled into first and second generation homo- and mixed polyester dendrimers.

1-(2H)-ISOQUINOLONE DERIVATIVE

-

Page/Page column 191, (2008/06/13)

The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 433686-87-4